VacV will be attending and presenting at The Cell and Gene Therapy Catapult Investors Day event aiming to bring together early-stage therapy developers and suitable investors to help accelerate their cell and gene therapy concepts toward patient benefit.
Committed to the advancement of cell and gene therapies with a vision of a thriving industry delivering life-changing advanced therapies to the world. Its aim is to create powerful collaborations which overcome challenges to the advancement of the sector.